Laboratory Reporting of Staphylococcus aureus with Reduced Susceptibility to Vancomycin in United States Department of Veterans Affairs Facilities1
Open Access
- 1 April 2002
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (4) , 402-407
- https://doi.org/10.3201/eid0804.010245
Abstract
Volume 22, Number 8—August 2016 - Emerging Infectious Disease journal - CDCThis publication has 18 references indexed in Scilit:
- Extremely low prevalence of UK Staphylococcus aureus isolates with reduced susceptibility to vancomycin.Journal of Antimicrobial Chemotherapy, 2001
- Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureusEmerging Infectious Diseases, 2001
- Ability of Laboratories To Detect Emerging Antimicrobial Resistance: Proficiency Testing and Quality Control Results from the World Health Organization's External Quality Assurance System for Antimicrobial Susceptibility TestingJournal of Clinical Microbiology, 2001
- Vancomycin-Intermediate and -Resistant Staphylococcus aureus: What the Infectious Disease Specialist Needs to KnowClinical Infectious Diseases, 2001
- Twenty months of screening for glycopeptide-intermediateStaphylococcus aureusJournal of Antimicrobial Chemotherapy, 2000
- Laboratory capacity to detect antimicrobial resistance, 1998.2000
- New Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureusFEMS Microbiology Letters, 1992
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987